Correction to: Role of antibody engineering in generation of derivatives starting from MOv19 MAb: 40 years of biological/therapeutic tools against folate receptor alfa

[This corrects the article DOI: 10.1093/abt/tbac026.]. © The Author(s) 2024. Published by Oxford University Press on behalf of Antibody Therapeutics.